What can we learn from Wolf Warriors 2?
Release time:
2020-08-14
What can we learn from Wolf Warriors 2 ?
The summer of 2017 in China was detonated by a domestic movie. From the release of 7 28 , "Wolf Warriors 2 " has been soaring all the way. From the unfavorable and uncertain before the release to the daily box office breaking 100 million yuan in a row, it easily topped the domestic box office in just half a month, and then entered the global film history box office TOP100 , winning the "number one" in the number of movie viewers in a single region. In the past month or more than a month, despite the numerous "encirclement and suppression" of domestic and foreign star blockbusters, "Wolf Warriors 2 " still firmly occupies a place in the top few of the Japanese box office rankings, and has surpassed 56 .9 billion, which everyone could not imagine before it was released. Results.
With the success of "Wolf Warriors 2 ", Wu Jing, who is a collection of editors, directors and actors, has also successfully transformed from a not-so-bright action "star". One film has thrown out the box office of many "famous directors" who have the right to speak in the industry for several blocks in their lifetime. Of course, how this movie should be evaluated is not the content of this article to discuss; what we want to analyze and discuss here is what we, as entrepreneurs, can learn from "Wolf Warriors 2 "?
No one's success will be a pie that falls out of thin air and just falls into your arms. From the stories in the film and the many news reports in front of and behind the stage, it is not difficult to find the success track of Wu Jing and "Wolf Warriors 2 .
The spirit of never giving up. In the film, Leng Feng, played by Wu Jing, went deep into the war-torn hinterland to rescue his compatriots. While fighting the rebels and mercenaries to death, he was also suspected by the rescuers and tortured by infectious diseases. In just 48 hours, he experienced several tests of life and death and finally completed the rescue mission. Outside the film, Wu Jing, as the director, put on all his belongings and owed countless human feelings and foreign debts, be prepared for the dangers of viruses and wars at all times when shooting in Africa. What impresses the audience is the great power feelings of "not giving up any compatriot". The film can be filmed and produced, and it also comes from the spirit of the whole crew never giving up.
Accumulation from quantitative change to qualitative change. Wu Jing made his debut as a kung fu niche and has been a supporting role in the Hong Kong film industry for many years. While suffering from the huge gap between ideal and reality, Wu Jing is constantly learning from those around him who look up to or look down on him. In addition to acting, it is more important to learn the whole production process of the film. Through more than ten years of accumulation of supporting actors, villains, and box lunch actors, he was able to achieve a magnificent turn with two "Wolf Warriors" after returning to the mainland.
Pre-target preparation. Shooting the "Wolf Warriors" series is a "big chess" under Wu Jing ". The first is the choice of goals. Under the circumstances that various types of films flood the market and make the audience have "difficulty in choosing", how to take the pulse of the quasi-market and the Chinese audience is undoubtedly the key to determine whether they can succeed in the future. The second is the preparation of the target. In order to shoot "Wolf Warriors", Wu Jing worked in the special forces for 18 months. In addition to military skills such as firearms and fighting, he also had to learn to fly airplanes and tanks. Wu Gang, an old man, insisted on keeping fit while filming "In the Name of the People". As soon as the TV series was finished, he entered the army and began to strictly "military training" from holding guns and aiming... Because of such preparation, many details in the film will be recognized by the majority of "military fans", win countless "tap water", and achieve a blowout word-of-mouth marketing.
Fully adjustable plan. According to relevant reports, the script of the "Wolf Warriors" series was already formed in the first part. Due to problems in the review of the second script, "Wolf Warriors 2 " was actually the third part. Just think, if there was no "alternative" for the third script, the initial investment in setting up the production team and purchasing equipment would have already ruined Wu Jing. Can you see this movie this summer, not to mention the missed market opportunities?
Be good at finding and using external resources. In all fairness, the cost of a 0.2 billion of "Wolf Warriors 2 " is not a large-scale production in the current domestic films, but many shots may not be able to be shot by burning money. For example, the deployment of tanks, missiles and ordnance is something that many directors dare not even think about. Why can Wu Jing do it? Looking at the list of production units and acknowledgement units at the beginning and end of the film, it is not difficult to find the mystery.
Excelsior attitude. With the popularity of "Wolf Warriors 2 ", the news that Wu Jing crouched on a tank to pick up a box lunch, almost drowned in underwater fighting, experienced all the action scenes personally, and invested nearly 100 million yuan over budget for post-production is also well known. However, only "military fans" who have seen the movie will notice such details as "the sound of shell shells popping up when shooting. Details that are destined to be ignored by most people can be "picked out" seriously. With this attitude, how can one worry about whether things can be done well?
Of course, there are many other factors for the success of "Wolf Warriors 2 ", such as the domestic and international situation, the rise of China, the change of Chinese mentality, the change of domestic film market pattern, etc., which may be called "external market opportunities". We can also say that the future "Wolf Warriors 3 " will hardly achieve the box office results of "Wolf Warriors 2 . However, for Dengfeng International, which is in charge of Wu Jing, "Wolf Warriors 2 " is a real successful case of enterprise project operation, which is worthy of our enterprise managers to ponder and learn. (Hong Tao)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31